3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
6
Phase 2
3
Phase 3
2
Phase 1/2
2
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Conditions
Ovarian Neoplasms
28
Small Cell Lung Carcinoma
24
Fallopian Tube Neoplasms
12
Uterine Cervical Neoplasms
8
Carcinoma, Ovarian Epithelial
8
Neuroblastoma
7
Lung Neoplasms
6
Sarcoma
3
Neoplasms
3
Retinoblastoma
2
Neoplasm Metastasis
2
Malignant mesenchymal tumor
2
Ganglioneuroblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Solid Tumors
1
SCLC
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Peritoneal Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Localized Extraskeletal Ewing Sarcoma
1
Leukemia
1
Eye Neoplasms
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Endometrial Neoplasms
1
Carcinoma
1
Interventions
Leucovorin
22
Fluorouracil
22
Gemcitabine
21
Capecitabine
21
Paclitaxel
20
Docetaxel
20
Irinotecan
15
Carboplatin
15
Radiosurgery
14
Oxaliplatin
13
Cisplatin
13
Bevacizumab
13
Zoledronic Acid
12
pembrolizumab
11
Radiotherapy
11
Fulvestrant
11
palbociclib
9
Pemetrexed
9
Drug Therapy
9
130-nm albumin-bound paclitaxel
9
Surgical Procedures, Operative
7
Letrozole
7
Ibandronic Acid
7
abemaciclib
6
Trastuzumab
6
Prednisone
6
Vinorelbine
5
Folfox protocol
5
Floxuridine
5
Doxorubicin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Neoplasm Metastasis
×
Topotecan
×
Clear all
NCT07213804
2026-05-27
FRAmework-01
Eli Lilly and Company
Phase 3
Recruiting
1,080 enrolled
NCT03061812
2021-02-23
TAHOE
AbbVie
Phase 3
Completed
444 enrolled
16 charts